Puma Biotechnology Q3 EPS $(0.44) Beats $(0.71) Estimate, Sales $56.4M Miss $60.4M Estimate

Puma Biotechnology (NYSE:PBYI) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.71) by 38.03 percent. This is a 18.92 percent decrease over losses of $(0.37) per share from

Benzinga · 11/06/2019 21:16

Puma Biotechnology (NYSE:PBYI) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.71) by 38.03 percent. This is a 18.92 percent decrease over losses of $(0.37) per share from the same period last year. The company reported quarterly sales of $56.4 million which missed the analyst consensus estimate of $60.4 million by 6.62 percent. This is a 9.90 percent decrease over sales of $62.6 million the same period last year.